Kate Lynn J. Bill

517 total citations
10 papers, 396 citations indexed

About

Kate Lynn J. Bill is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kate Lynn J. Bill has authored 10 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Kate Lynn J. Bill's work include Sarcoma Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Kate Lynn J. Bill is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Kate Lynn J. Bill collaborates with scholars based in United States, Israel and France. Kate Lynn J. Bill's co-authors include Raphael E. Pollock, Dina Lev, Gonzalo Lopez, Danielle Braggio, Lucia Casadei, Bethany C. Prudner, Chad J. Creighton, Kara Batte, Abeba Zewdu and Hemant K. Bid and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kate Lynn J. Bill

10 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Lynn J. Bill United States 8 253 164 147 117 41 10 396
Ngoc T. Hoang United States 6 274 1.1× 130 0.8× 200 1.4× 155 1.3× 23 0.6× 8 467
Danielle Braggio United States 13 339 1.3× 195 1.2× 170 1.2× 123 1.1× 34 0.8× 19 556
Vanessa Chaire France 11 137 0.5× 55 0.3× 171 1.2× 181 1.5× 32 0.8× 19 315
K. Hoekman Netherlands 6 166 0.7× 72 0.4× 60 0.4× 128 1.1× 36 0.9× 11 323
Joanna Vitfell-Rasmussen United Kingdom 5 165 0.7× 39 0.2× 94 0.6× 134 1.1× 13 0.3× 6 337
Catherine Copigneaux United States 9 206 0.8× 49 0.3× 109 0.7× 259 2.2× 13 0.3× 17 419
Tomohiro Kumamoto Japan 14 501 2.0× 437 2.7× 108 0.7× 70 0.6× 7 0.2× 21 635
Banzhou Pan China 14 476 1.9× 414 2.5× 89 0.6× 133 1.1× 19 0.5× 22 713
Shican Yan China 9 225 0.9× 181 1.1× 79 0.5× 163 1.4× 7 0.2× 11 434
Mengna Zhan China 9 253 1.0× 201 1.2× 34 0.2× 77 0.7× 16 0.4× 13 367

Countries citing papers authored by Kate Lynn J. Bill

Since Specialization
Citations

This map shows the geographic impact of Kate Lynn J. Bill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Lynn J. Bill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Lynn J. Bill more than expected).

Fields of papers citing papers by Kate Lynn J. Bill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Lynn J. Bill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Lynn J. Bill. The network helps show where Kate Lynn J. Bill may publish in the future.

Co-authorship network of co-authors of Kate Lynn J. Bill

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Lynn J. Bill. A scholar is included among the top collaborators of Kate Lynn J. Bill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Lynn J. Bill. Kate Lynn J. Bill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bill, Kate Lynn J., Nathan D. Seligson, John L. Hays, et al.. (2019). Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma. The Oncologist. 24(7). 989–996. 28 indexed citations
2.
Yu, Peter Y., Gonzalo Lopez, Danielle Braggio, et al.. (2018). miR-133a function in the pathogenesis of dedifferentiated liposarcoma. Cancer Cell International. 18(1). 89–89. 14 indexed citations
3.
Casadei, Lucia, Federica Calore, Chad J. Creighton, et al.. (2017). Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression. Cancer Research. 77(14). 3846–3856. 149 indexed citations
4.
Bill, Kate Lynn J., et al.. (2016). Liposarcoma: molecular targets and therapeutic implications. Cellular and Molecular Life Sciences. 73(19). 3711–3718. 35 indexed citations
5.
Bill, Kate Lynn J., Jeannine Garnett, Isabelle Meaux, et al.. (2015). SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clinical Cancer Research. 22(5). 1150–1160. 86 indexed citations
6.
Lopez, Gonzalo, Chad J. Creighton, Hemant K. Bid, et al.. (2015). HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components. Molecular Cancer Research. 14(1). 35–43. 17 indexed citations
7.
Lopez, Gonzalo, Kate Lynn J. Bill, Hemant K. Bid, et al.. (2015). HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST). PLoS ONE. 10(7). e0133302–e0133302. 49 indexed citations
8.
Bill, Kate Lynn J., Jeannine Garnett, Xiaoyan Ma, et al.. (2015). The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma. Laboratory Investigation. 95(8). 951–961. 13 indexed citations
9.
Culp, Stephen H., E. Jason Abel, Vitaly Margulis, et al.. (2009). IDENTIFYING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY. The Journal of Urology. 181(4S). 498–498. 2 indexed citations
10.
Abel, E. Jason, Stephen H. Culp, Lambros Stamatakis, et al.. (2009). PERCUTANEOUS PRIMARY TUMOR BIOPSY IS UNRELIABLE TO PREDICT HIGH RISK PATHOLOGIC FEATURES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA. The Journal of Urology. 181(4S). 501–501. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ngoc T. Hoang Breakdown of academic impact, for papers by Danielle Braggio Breakdown of academic impact, for papers by Vanessa Chaire Breakdown of academic impact, for papers by K. Hoekman Breakdown of academic impact, for papers by Joanna Vitfell-Rasmussen Breakdown of academic impact, for papers by Catherine Copigneaux Breakdown of academic impact, for papers by Tomohiro Kumamoto Breakdown of academic impact, for papers by Banzhou Pan Breakdown of academic impact, for papers by Shican Yan Breakdown of academic impact, for papers by Mengna Zhan
Rankless by CCL
2026